Saranacentral Bajatama Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Saranacentral Bajatama Tbk trades at Rp161 (market cap 288B, 1.21M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Saranacentral Bajatama Tbk and Diagnos Laboratorium Utama Tbk. are close in size by market cap, and Saranacentral Bajatama Tbk is more actively traded (1.21M versus 159.2K). Which is the better fit depends on your goals.
| BAJA | DGNS | |
|---|---|---|
Market Cap | 288B | 310.75B |
Volume | 1.21M | 159.2K |
Lot | 12.09K | 1.59K |
Turnover | 193.62M | 34.72M |
Average Price | 160.18 | 218.06 |
Value | 193.62M | 34.72M |
Indicative Equilibrium Price | 161 | 220 |
Indicative Equilibrium Volume | 4 | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Saranacentral Bajatama (SCB), established in 1996, is belonging to Sarana Steel Group, which was set up in 1970 and has built up its strong reputation in the worldwide steel industry. In order to provide competitive Hot-Dip Galvanized Steel Sheet/Coil to the customers, SCB take advantage of more advanced NOF (Non-Oxidation Furnace) System for production process, by which SCB differentiate itself from other competitors that use conventional processing system.
Read more on BAJA →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →